These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 5075351)
1. Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer. Stolinsky DC; Bogdon DL; Solomon J; Bateman JR Cancer; 1972 Sep; 30(3):654-9. PubMed ID: 5075351 [No Abstract] [Full Text] [Related]
2. Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388). Luce JK; Thurman WG; Isaacs BL; Talley RW Cancer Chemother Rep; 1970 Apr; 54(2):119-24. PubMed ID: 4334086 [No Abstract] [Full Text] [Related]
3. 5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma. Carter SK; Friedman MA Eur J Cancer (1965); 1972 Feb; 8(1):85-92. PubMed ID: 4552317 [No Abstract] [Full Text] [Related]
4. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma]. Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U Tumori; 1973; 59(3):239-48. PubMed ID: 4729646 [No Abstract] [Full Text] [Related]
5. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma. Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016 [No Abstract] [Full Text] [Related]
6. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children. Finklestein JZ; Albo V; Ertel I; Karon M; Hammond D Cancer Chemother Rep; 1972 Aug; 56(4):523-6. PubMed ID: 4507686 [No Abstract] [Full Text] [Related]
7. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma. Falkson G; Van der Merwe AM; Falkson HC Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061 [No Abstract] [Full Text] [Related]
8. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma. Kingra GS; Comis R; Olson KB; Horton J Cancer Chemother Rep; 1971 Jun; 55(3):281-3. PubMed ID: 5115849 [No Abstract] [Full Text] [Related]
9. Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma. Gerner RE; Moore GE Cancer Chemother Rep; 1973 Feb; 57(1):83-4. PubMed ID: 4704107 [No Abstract] [Full Text] [Related]
10. Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide. Gottlieb JA; Baker LH; Quagliana JM; Luce JK; Whitecar JP; Sinkovics JG; Rivkin SE; Brownlee R; Frei E Cancer; 1972 Dec; 30(6):1632-8. PubMed ID: 4663966 [No Abstract] [Full Text] [Related]
11. Hexamethylmelamine (NSC-13875) for acute leukemia and solid tumors in children. Dyment PG; Fernbach DJ; Sutow WW J Clin Pharmacol New Drugs; 1973; 13(2):111-3. PubMed ID: 4568295 [No Abstract] [Full Text] [Related]
12. Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Gams RA; Carpenter JT Cancer Chemother Rep; 1974; 58(5 Pt 1):753-4. PubMed ID: 4214608 [No Abstract] [Full Text] [Related]
13. Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma. Einhorn LH; McBride CM; Luce JK; Caoili E; Gottlieb JA Cancer; 1973 Oct; 32(4):749-55. PubMed ID: 4751911 [No Abstract] [Full Text] [Related]
14. Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin. Gerner RE; Moore GE; Didolkar MS Cancer; 1973 Oct; 32(4):756-60. PubMed ID: 4751912 [No Abstract] [Full Text] [Related]
15. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma. Frei E; Luce JK; Talley RW; Vaitkevicius VK; Wilson HE Cancer Chemother Rep; 1972 Oct; 56(5):667-70. PubMed ID: 4569060 [No Abstract] [Full Text] [Related]
16. Hexamethylmelamine (NSC-13875) in the treatment of advanced cancer. Wampler GL; Mellette SJ; Kuperminc M; Regelson W Cancer Chemother Rep; 1972 Aug; 56(4):505-14. PubMed ID: 5081594 [No Abstract] [Full Text] [Related]
17. Effective treatment of Kaposi's sarcoma with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Vogel CL; Primack A; Owor R; Kyalwazi SK Cancer Chemother Rep; 1973 Feb; 57(1):65-71. PubMed ID: 4704105 [No Abstract] [Full Text] [Related]
18. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer. Falkson G; van Eden EB; Falkson HC Cancer; 1974 May; 33(5):1207-9. PubMed ID: 4595974 [No Abstract] [Full Text] [Related]
19. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma. Ahmann DL; Hahn RG; Bisel HF Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357 [No Abstract] [Full Text] [Related]
20. Phase II study of 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in advanced gastrointestinal cancer. Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG Cancer Chemother Rep; 1972 Apr; 56(2):267-9. PubMed ID: 5043230 [No Abstract] [Full Text] [Related] [Next] [New Search]